Production (Stage)
Ensysce Biosciences, Inc.
ENSC
$2.07
-$0.07-3.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 37.58% | -1.74% | 124.61% | 11.84% | -42.46% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -100.00% | -- | -- | -- |
| Total Other Non-Cash Items | 6.95% | -92.45% | -58.71% | -22.85% | 120.65% |
| Change in Net Operating Assets | 112.07% | 270.96% | -545.07% | 56.99% | -29.67% |
| Cash from Operations | 49.91% | 57.59% | 54.91% | 25.69% | 5.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.61% | 33.36% | 30.34% | 91.25% | -3.05% |
| Issuance of Common Stock | -30.22% | -- | -- | -100.00% | -22.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.36% | -- | -- | 100.00% | 2,292.16% |
| Cash from Financing | -77.89% | -92.29% | 4,129.95% | -100.93% | 203.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.71% | -91.17% | 231.51% | -197.82% | 231.69% |